Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sequester, Shutdown Hurt FDA Recruitment, Morale – Hamburg

This article was originally published in The Tan Sheet

Executive Summary

The FDA commissioner tells a House subcommittee that a job candidate questioned whether the “uncertainty” of government work was worth leaving academia, creating another hurdle for agency efforts to fill senior leadership positions.

Advertisement

Related Content

Shutdown Winds Down: Short 'Lapse Period' Likely Means Few Disruptions At US FDA
US FDA Enters Shutdown Mode: Reviews Will Continue, But Will Morale?
FDA's Government Shutdown Plan Ready, Just In Case
Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA
FDA Shutdown Lands Hard On CFSAN-Regulated Industries
Sequester Travel: Halved FDA Budget Limits Opportunities For Scientists, Impacts Senior Officials Too
FDA Widens Search For Medical Products, Tobacco Deputy Commissioner
PDUFA Communications Hurt By Sequestration As Late-Stage Meetings Begin

Topics

Advertisement
UsernamePublicRestriction

Register

PS106857

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel